{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:37:07Z","timestamp":1765539427916,"version":"3.48.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To present a rare case of cryptococcal pericarditis with unexplained multiple lymphadenopathies in an immunocompetent patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fungal pericarditis is an uncommon infection that may result from hematogenous dissemination, direct extension, or iatrogenic inoculation. Cryptococcal pericarditis typically occurs in immunocompromised hosts and is exceedingly rare in immunocompetent individuals. We describe a case of cryptococcal pericarditis with multiple lymphadenopathies in an immunocompetent patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report<\/jats:title>\n                    <jats:p>A 40-year-old male with no underlying disease or history of high-risk behaviors presented with chronic cough and sputum production. Imaging revealed bilateral pulmonary lesions, widespread lymphadenopathy, and pericardial effusion. Serum and pericardial fluid cryptococcal antigen tests were positive. HIV testing (fourth-generation antigen\/antibody ELISA) was negative, and immunologic evaluation was unremarkable. Pericardiocentesis drained 585 mL of effusion. The patient was treated with intravenous antifungal therapy with fluconazole (0.4 g daily) for 1 week, followed by oral fluconazole for 4 months. Follow-up echocardiography performed 2 weeks after discharge revealed no significant pericardial effusion, whereas a subsequent at 4 months after discharge demonstrated a small residual effusion. The patient's cough and sputum production had also improved. Throughout the hospitalization and post-discharge period, the patient was able to maintain normal physical activity without functional limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This report presents a rare case of cryptococcal pericarditis with unexplained multiple lymphadenopathies in an immunocompetent patient, highlighting that fungal infection should be considered even in immunocompetent hosts with pericarditis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1688934","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:34:14Z","timestamp":1765539254000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cryptococcal pericarditis with unexplained lymphadenopathy in an immunocompetent patient: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Jie","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/microorganisms13040707","article-title":"Fungal pericarditis-A systematic review of 101 cases","volume":"13","author":"Jancic","year":"2025","journal-title":"Microorganisms."},{"key":"B2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Kwon-Chung","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"White: hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1128\/IAI.00542-09","article-title":"Spores as infectious propagules of Cryptococcus neoformans","volume":"77","author":"Velagapudi","year":"2009","journal-title":"Infect Immun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3201\/eid2810.220391","article-title":"Demographic and socioeconomic factors associated with fungal infection risk, United States, 2019","volume":"28","author":"Rayens","year":"2022","journal-title":"Emerg Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1128\/jb.150.3.1212-1220.1982","article-title":"Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans","volume":"150","author":"Polacheck","year":"1982","journal-title":"J Bacteriol"},{"key":"B8","first-page":"e1004285","article-title":"Cryptococcus gattii VGIII isolates causing infections in HIV\/AIDS patients in Southern California: identification of the local environmental source as arboreal","volume-title":"PLoS Pathog","author":"Springer","year":"2014"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841X.2011.606426","article-title":"Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update","volume":"38","author":"Chowdhary","year":"2012","journal-title":"Crit Rev Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e19688","DOI":"10.1371\/journal.pone.0019688","article-title":"Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa","volume":"6","author":"Litvintseva","year":"2011","journal-title":"PLoS ONE."},{"key":"B11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1574-6976.2011.00286.x","article-title":"Profiling a killer, the development of Cryptococcus neoformans","volume":"36","author":"Kozubowski","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-micro-020518-120210","article-title":"Life cycle of Cryptococcus neoformans","volume":"73","author":"Zhao","year":"2019","journal-title":"Annu Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105521","DOI":"10.1016\/j.micpath.2022.105521","article-title":"A holistic review on Cryptococcus neoformans","volume":"166","author":"Rathore","year":"2022","journal-title":"Microb Pathog"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/microorganisms10122419","article-title":"Cryptococcal immune reconstitution inflammatory syndrome: from clinical studies to animal experiments","volume":"10","author":"Shi","year":"2022","journal-title":"Microorganisms."},{"key":"B15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-pathol-012513-104653","article-title":"The intracellular life of Cryptococcus neoformans","volume":"9","author":"Coelho","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/22221751.2021.1894902","article-title":"Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou","volume":"10","author":"Li","year":"2021","journal-title":"China Emerg Microbes Infect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0039-3400280","article-title":"Cryptococcosis","volume":"41","author":"Zavala","year":"2020","journal-title":"Semin Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e15362","DOI":"10.7759\/cureus.15362","article-title":"Disseminated cryptococcosis in an immunocompetent child","volume":"13","author":"Vijayasekharan","year":"2021","journal-title":"Cureus."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00167","DOI":"10.1002\/rcr2.167","article-title":"Disseminated cryptococcosis presenting as mediastinal and hilar lymphadenopathy in an immunocompetent patient","volume":"4","author":"Murakami","year":"2016","journal-title":"Respirol Case Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10096-008-0529-z","article-title":"Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease","volume":"27","author":"Baddley","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/mmy\/myy086","article-title":"Pulmonary cryptococcosis: a review of pathobiology and clinical aspects","volume":"57","author":"Setianingrum","year":"2019","journal-title":"Med Mycol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e01297","DOI":"10.1002\/rcr2.1297","article-title":"Isolated cryptococcal pleural effusion in a heart transplant recipient: a case report and literature review of pleural fluid adenosine deaminase levels","volume":"12","author":"Lee","year":"2024","journal-title":"Respirol Case Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.23736\/S0031-0808.20.04197-X","article-title":"Contemporary management of pericardial effusion","volume":"63","author":"Lazaros","year":"2021","journal-title":"Panminerva Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14779072.2022.2075346","article-title":"Chronic pericardial effusion: current concepts and emerging trends","volume":"20","author":"Lazaros","year":"2022","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11886-021-01539-7","article-title":"New approaches to management of pericardial effusions","volume":"23","author":"Lazaros","year":"2021","journal-title":"Curr Cardiol Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1128\/IAI.00334-09","article-title":"Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans","volume":"77","author":"Giles","year":"2009","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e69804","DOI":"10.1371\/journal.pone.0069804","article-title":"Development of an aerosol model of cryptococcus reveals humidity as an important factor affecting the viability of cryptococcus during aerosolization","volume":"8","author":"Springer","year":"2013","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"fow045","DOI":"10.1093\/femsyr\/fow086","article-title":"Environmental distribution of Cryptococcus neoformans and C. gattii around the mediterranean basin","volume":"16","author":"Cogliati","year":"2016","journal-title":"FEMS Yeast Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7861\/clinmedicine.19-2-133","article-title":"Idiopathic CD4 lymphopenia in a case of disseminated cryptococcosis with brain, vertebral spine and reproductive organ involvement","volume":"19","author":"Sim","year":"2019","journal-title":"Clin Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1688934\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:34:14Z","timestamp":1765539254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1688934\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1688934"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1688934","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"article-number":"1688934"}}